|
1
|
Hu FB, Manson JE, Stampfer MJ, Colditz G,
Liu S, Solomon CG and Willett WC: Diet, lifestyle, and the risk of
type 2 diabetes mellitus in women. N Engl J Med. 345:790–797. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pittas AG, Lau J, Hu FB and Dawson-Hughes
B: The role of vitamin D and calcium in type 2 diabetes. A
systematic review and meta-analysis. J Clin Endocrinol Metab.
92:2017–2029. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iso H: Changes in coronary heart disease
risk among Japanese. Circulation. 118:2725–2729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valmadrid CT, Klein R, Moss SE and Klein
BE: The risk of cardiovascular disease mortality associated with
microalbuminuria and gross proteinuria in persons with older-onset
diabetes mellitus. Arch Intern Med. 160:1093–1100. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053.
2004.PubMed/NCBI
|
|
6
|
Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki
CM and Herman WH: Does microalbuminuria predict diabetic
nephropathy? Diabetes Care. 24:1560–1566. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang H, Guan G, Zhang R, Liu G, Cheng J,
Hou X and Cui Y: Identification of urinary soluble E-cadherin as a
novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev.
25:232–241. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li F, Chen DN, He CW, Zhou Y, Olkkonen VM,
He N, Chen W, Wan P, Chen SS, Zhu YT, Lan KJ and Tan WL:
Identification of urinary Gc-globulin as a novel biomarker for
bladder cancer by two-dimensional fluorescent differential gel
electrophoresis (2D-DIGE). J Proteomics. 77:225–236. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thrailkill KM, Jo CH, Cockrell GE, Moreau
CS and Fowlkes JL: Enhanced excretion of vitamin D binding protein
in type 1 diabetes: a role in vitamin D deficiency? J Clin
Endocrinol Metab. 96:142–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cho S, Choi YS, Yim SY, Yang HI, Jeon YE,
Lee KE, Kim H, Seo SK and Lee BS: Urinary vitamin D-binding protein
is elevated in patients with endometriosis. Hum Reprod. 27:515–522.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanley JA and McNeil BJ: The meaning and
use of the area under a receiver operating characteristic (ROC)
curve. Radiology. 143:29–36. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang H, Guan G, Zhang R, Liu G, Liu H,
Hou X and Cheng J: Increased urinary excretion of orosomucoid is a
risk predictor of diabetic nephropathy. Nephrology (Carlton).
14:332–337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dihazi H and Müller GA: Urinary
proteomics: a tool to discover biomarkers of kidney diseases.
Expert Rev Proteomics. 4:39–50. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Varghese SA, Powell TB, Budisavljevic MN,
Oates JC, Raymond JR, Almeida JS and Arthur JM: Urine biomarkers
predict the cause of glomerular disease. J Am Soc Nephrol.
18:913–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cooke NE and David EV: Serum vitamin
D-binding protein is a third member of the albumin and alpha
fetoprotein gene family. J Clin Invest. 76:2420–2424. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chun RF, Peercy BE, Adams JS and Hewison
M: Vitamin D binding protein and monocyte response to
25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by
mathematical modeling. PLoS One. 7:e307732012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christakos S, Ajibade DV, Dhawan P,
Fechner AJ and Mady LJ: Vitamin D: metabolism. Endocrinol Metab
Clin North Am. 39:243–253. 2010. View Article : Google Scholar
|
|
18
|
Yamamoto N and Naraparaju VR: Vitamin
D3-binding protein as a precursor for macrophage activating factor
in the inflammation-primed macrophage activation cascade in rats.
Cell Immunol. 170:161–167. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gregory KJ, Zhao B, Bielenberg DR, Dridi
S, Wu J, Jiang W, Huang B, Pirie-Shepherd S and Fannon M: Vitamin D
binding protein-macrophage activating factor directly inhibits
proliferation, migration, and uPAR expression of prostate cancer
cells. PLoS One. 5:e134282010. View Article : Google Scholar
|
|
20
|
Yamamoto N, Naraparaju VR and Asbell SO:
Deglycosylation of serum vitamin D3-binding protein leads to
immunosuppression in cancer patients. Cancer Res. 56:2827–2831.
1996.PubMed/NCBI
|
|
21
|
Yamamoto N, Suyama H, Nakazato H, Yamamoto
N and Koga Y: Immunotherapy of metastatic colorectal cancer with
vitamin D-binding protein-derived macrophage-activating factor,
GcMAF. Cancer Immunol Immunother. 57:1007–1016. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nykjaer A, Dragun D, Walther D, Vorum H,
Jacobsen C, Herz J, Melsen F, Christensen EI and Willnow TE: An
endocytic pathway essential for renal uptake and activation of the
steroid 25-(OH) vitamin D3. Cell. 96:507–515. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zehnder D, Bland R, Williams MC, McNinch
RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of
25-hydroxyvitamin D3-1α-hydroxylase. J Clin Endocrinol
Metab. 86:888–894. 2001.PubMed/NCBI
|
|
24
|
Colston K, Williams NJ and Cleeve HJ:
Studies on vitamin D binding protein in the nephrotic syndrome.
Clin Chem. 31:718–721. 1985.PubMed/NCBI
|
|
25
|
Vilasi A, Cutillas PR, Maher AD, Zirah SF,
Capasso G, Norden AW, Holmes E, Nicholson JK and Unwin RJ: Combined
proteomic and metabonomic studies in three genetic forms of the
renal Fanconi syndrome. Am J Physiol Renal Physiol. 293:F456–F467.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Uchida M, Teranishi H, Aoshima K, Katoh T,
Kasuya M and Inadera H: Elevated urinary levels of vitamin
D-binding protein in the inhabitants of a cadmium polluted area,
Jinzu River basin, Japan. Tohoku J Exp Med. 211:269–274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Svoren BM, Volkening LK, Wood JR and
Laffel LM: Significant vitamin D deficiency in youth with type 1
diabetes mellitus. J Pediatr. 154:132–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tahrani AA, Ball A, Shepherd L, Rahim A,
Jones AF and Bates A: The prevalence of vitamin D abnormalities in
South Asians with type 2 diabetes mellitus in the UK. Int J Clin
Pract. 64:351–355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mirković K, Doorenbos CR, Dam WA, Lambers
Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van
den Born J, Navis G and de Borst MH: Urinary vitamin D binding
protein: a potential novel marker of renal interstitial
inflammation and fibrosis. PLoS One. 8:e558872013.PubMed/NCBI
|
|
30
|
Zoidakis J, Makridakis M, Zerefos PG,
Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP,
Roubelakis MG, Sanchez-Carbayo M and Vlahou A: Profilin 1 is a
potential biomarker for bladder cancer aggressiveness. Mol Cell
Proteomics. 11:M111.0094492012. View Article : Google Scholar
|
